Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

Authors:
  • HBHany Bissada
    Hany Bissada
  • GTGiorgio A. Tasca
    Giorgio A. Tasca
  • MBM.A. Ann Marie Barber
    M.A. Ann Marie Barber
  • JBJacques Bradwejn
    Jacques Bradwejn
  • RRRobert Rosenheckm.D.
    Robert Rosenheckm.D.
  • TST. Scott Stroupm.D.
    T. Scott Stroupm.D.
  • MSM. Swartzm.D.
    M. Swartzm.D.
  • JMJOSEPH McEVOYM.D.
    JOSEPH McEVOYM.D.
  • DDDr.P. H. Sonia M. Davis
    Dr.P. H. Sonia M. Davis
  • RKRichard S.E. Keefeph.D.
    Richard S.E. Keefeph.D.
  • JHJohn K. Hsiaom.D.
    John K. Hsiaom.D.
  • JLJ. Liebermanm.D.
    J. Liebermanm.D.
Publisher website
Google Scholar
Abstract
OBJECTIVE: This international, multicenter double-blind trial was designed to compare the therapeutic profile of an atypical antipsychotic, olanzapine, with that of a conventional dopamine D2 antag...

This publication has 28 references indexed in Scilit: